Lung-gut Axis of Microbiome Alterations Following Co-exposure to Ultrafine Carbon Black and Ozone
Overview
Authors
Affiliations
Background: Microbial dysbiosis is a potential mediator of air pollution-induced adverse outcomes. However, a systemic comparison of the lung and gut microbiome alterations and lung-gut axis following air pollution exposure is scant. In this study, we exposed male C57BL/6J mice to inhaled air, CB (10 mg/m), O (2 ppm) or CB + O mixture for 3 h/day for either one day or four consecutive days and were euthanized 24 h post last exposure. The lung and gut microbiome were quantified by 16 s sequencing.
Results: Multiple CB + O exposures induced an increase in the lung inflammatory cells (neutrophils, eosinophils and B lymphocytes), reduced absolute bacterial load in the lungs and increased load in the gut. CB + O exposure was more potent as it decreased lung microbiome alpha diversity just after a single exposure. CB + O co-exposure uniquely increased Clostridiaceae and Prevotellaceae in the lungs. Serum short chain fatty acids (SCFA) (acetate and propionate) were increased significantly only after CB + O co-exposure. A significant increase in SCFA producing bacterial families (Ruminococcaceae, Lachnospiraceae, and Eubacterium) were also observed in the gut after multiple exposures. Co-exposure induced significant alterations in the gut derived metabolite receptors/mediator (Gcg, Glp-1r, Cck) mRNA expression. Oxidative stress related mRNA expression in lungs, and oxidant levels in the BALF, serum and gut significantly increased after CB + O exposures.
Conclusion: Our study confirms distinct gut and lung microbiome alterations after CB + O inhalation co-exposure and indicate a potential homeostatic shift in the gut microbiome to counter deleterious impacts of environmental exposures on metabolic system.
Air-Pollution-Mediated Microbial Dysbiosis in Health and Disease: Lung-Gut Axis and Beyond.
Mazumder M, Hussain S J Xenobiot. 2024; 14(4):1595-1612.
PMID: 39449427 PMC: 11503347. DOI: 10.3390/jox14040086.
Agarwal S, Tomar N, Makwana M, Patra S, Chopade B, Gupta V Future Microbiol. 2024; 19(17):1497-1513.
PMID: 39345043 PMC: 11492635. DOI: 10.1080/17460913.2024.2401263.
He L, Luo H, Li Y, Zhang Y, Peng L, Xu Y Medicine (Baltimore). 2024; 103(22):e38331.
PMID: 39259083 PMC: 11142829. DOI: 10.1097/MD.0000000000038331.
Wang Y, Nie J, Yan K, Wang J, Wang X, Zhao Y Front Nutr. 2024; 11:1458484.
PMID: 39221159 PMC: 11363541. DOI: 10.3389/fnut.2024.1458484.
Li N, Tan G, Xie Z, Chen W, Yang Z, Wang Z Respir Res. 2024; 25(1):304.
PMID: 39127664 PMC: 11316369. DOI: 10.1186/s12931-024-02943-7.